(Press-News.org) Researchers from the Gene and Stem Cell Therapy Program at Sydney's Centenary Institute have confirmed that, far from being "junk", the 97 per cent of human DNA that does not encode instructions for making proteins can play a significant role in controlling cell development.
And in doing so, the researchers have unravelled a previously unknown mechanism for regulating the activity of genes, increasing our understanding of the way cells develop and opening the way to new possibilities for therapy.
Using the latest gene sequencing techniques and sophisticated computer analysis, a research group led by Professor John Rasko AO and including Centenary's Head of Bioinformatics, Dr William Ritchie, has shown how particular white blood cells use non-coding DNA to regulate the activity of a group of genes that determines their shape and function. The work is published today in the scientific journal Cell.
"This discovery, involving what was previously referred to as "junk", opens up a new level of gene expression control that could also play a role in the development of many other tissue types," Rasko says. "Our observations were quite surprising and they open entirely new avenues for potential treatments in diverse diseases including cancers and leukaemias."
The researchers reached their conclusions through studying introns—non-coding sequences which are located inside genes.
As part of the normal process of generating proteins from DNA, the code for constructing a particular protein is printed off as a strip of genetic material known as messenger RNA (mRNA). It is this strip of mRNA which carries the instructions for making the protein from the gene in the nucleus to the protein factories or ribosomes in the body of the cell.
But these mRNA strips need to be processed before they can be used as protein blueprints. Typically, any non-coding introns must be cut out to produce the final sequence for a functional protein. Many of the introns also include a short sequence—known as the stop codon—which, if left in, stops protein construction altogether. Retention of the intron can also stimulate a cellular mechanism which breaks up the mRNA containing it.
Dr Ritchie was able to develop a computer program to sort out mRNA strips retaining introns from those which did not. Using this technique the lead molecular biologist of the team, Dr Justin Wong, found that mRNA strips from many dozens of genes involved in white blood cell function were prone to intron retention and consequent break down. This was related to the levels of the enzymes needed to chop out the intron. Unless the intron is excised, functional protein products are never produced from these genes. Dr Jeff Holst in the team went a step further to show how this mechanism works in living bone marrow.
So the researchers propose intron retention as an efficient means of controlling the activity of many genes. "In fact, it takes less energy to break up strips of mRNA, than to control gene activity in other ways," says Rasko. "This may well be a previously-overlooked general mechanism for gene regulation with implications for disease causation and possible therapies in the future."
###Background information is online at http://www.scienceinpublic.com.au/centenary/junkdna
Media Contacts:
Tamzin Byrne
0432 974 400
tamzin@scienceinpublic.com.au
Prof John Rasko AO
0408 424 013
j.rasko@centenary.usyd.edu.au
Centenary Institute:
Jill Atherton
0466 166 878
j.atherton@centenary.org.au
How 'junk DNA' can control cell development
2013-08-02
ELSE PRESS RELEASES FROM THIS DATE:
Revised location of 1906 rupture of San Andreas Fault in Portola Valley
2013-08-02
SAN FRANCISCO -- New evidence suggests the 1906 earthquake ruptured the San Andreas Fault in a single trace through Portola Village, current day Town of Portola Valley, and indicates a revised location for the fault trace.
Portola Valley, south of San Francisco, has been extensively studied and the subject of the first geological map published in California. Yet studies have offered conflicting conclusions, caused in part by a misprinted photograph and unpublished data, as to the location and nature of the 1906 surface rupture through the area.
"It is critical for ...
New drugs to find the right target to fight Alzheimer's disease
2013-08-02
The future is looking good for drugs designed to combat Alzheimer's disease. EPFL scientists have unveiled how two classes of drug compounds currently in clinical trials work to fight the disease. Their research suggests that these compounds target the disease-causing peptides with high precision and with minimal side-effects. At the same time, the scientists offer a molecular explanation for early-onset hereditary forms of Alzheimer's, which can strike as early as thirty years of age. The conclusions of their research, which has been published in the journal Nature Communications, ...
Researchers create 'soft robotic' devices using water-based gels
2013-08-02
Researchers from North Carolina State University have developed a new technique for creating devices out of a water-based hydrogel material that can be patterned, folded and used to manipulate objects. The technique holds promise for use in "soft robotics" and biomedical applications.
"This work brings us one step closer to developing new soft robotics technologies that mimic biological systems and can work in aqueous environments," says Dr. Michael Dickey, an assistant professor of chemical and biomolecular engineering at NC State and co-author of a paper describing ...
Largest neuronal network simulation to date achieved using Japanese supercomputer
2013-08-02
By exploiting the full computational power of the Japanese supercomputer, K Computer, researchers from the RIKEN HPCI Program for Computational Life Sciences, the Okinawa Institute of Technology (OIST) in Japan and Forschungszentrum Jülich in Germany have carried out the largest general neuronal network simulation to date.
The simulation was made possible by the development of advanced novel data structures for the simulation software NEST. The relevance of the achievement for neuroscience lies in the fact that NEST is open-source software freely available to every scientist ...
Cobalt replacements make solar cells more sustainable
2013-08-02
Researchers at the University of Basel have successfully replaced the rare element iodine in copper-based dye-sensitized solar cells by the more abundant element cobalt, taking a step forward in the development of environmentally friendly energy production. The journal «Chemical Communications» has published the results of these so-called Cu-Co cells.
Dye-sensitized solar cells (DSCs) transform light to electricity. They consist of a semiconductor on which a dye is anchored. This colored complex absorbs light and through an electron transfer process produces electrical ...
Helping horses come to term
2013-08-02
As any nervous first-time mother will confirm, the initial three months of pregnancy are the most risky time: many expectant women are reluctant to inform their friends or colleagues that they are pregnant until after this period is past. It is less well known that horses suffer from similar problems, with a considerable number of pregnancies failing to progress beyond the first five weeks. The explanation is still unclear but may relate to a problem with the mare's immune system, as the latest work in the group of Christine Aurich in the Vetmeduni's Centre for Artificial ...
New findings could influence the development of therapies to treat dengue disease
2013-08-02
New research into the fight against Dengue, an insect-borne tropical disease that infects up to 390 million people worldwide annually, may influence the development of anti-viral therapies that are effective against all four types of the virus.
The findings, led by researchers at the University of Bristol and published in the Journal of Biological Chemistry today [2 August], show for the first time that there may be significant differences in specific properties of the viral proteins for the four dengue virus types.
Due to the effects of globalisation, including increased ...
Wired for change
2013-08-02
A study of gene expression led by scientists at the EMBL-European Bioinformatics Institute (EMBL-EBI) and the University of Cambridge has revealed the first steps of evolution in gene regulation in mice. Published in the journal Cell, the research has implications for the study of differences in gene regulation between people.
"We found an impressive amount of variation between these apparently very similar mice in terms of transcription-factor binding, which is an important indicator of gene-regulation activity," says Paul Flicek of EMBL-EBI. "Often you'll see a specific ...
Added benefit of lixisenatide is not proven
2013-08-02
Lixisenatide (trade name: Lyxumia) has been approved in Germany since February 2013 for the treatment of type 2 diabetes mellitus in combination with oral blood-glucose lowering drugs or basal insulin when these, together with diet and exercise, do not provide adequate glycaemic control. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products (AMNOG), the German Institute for Quality and Efficiency in Health Care (IQWiG) examined whether this new drug offers an added benefit over the current standard therapy. No such added benefit ...
Apixaban in atrial fibrillation: Indications of considerable added benefit
2013-08-02
The clot-inhibiting drug apixaban (trade name: Eliquis) has been approved in Germany since November 2012 for the prevention of embolism and stroke in adults with non-valvular atrial fibrillation. In an early benefit assessment pursuant to the "Act on the Reform of the Market for Medicinal Products" (AMNOG), the German Institute for Quality and Efficiency in Health Care (IQWiG) examined the added benefit of apixaban.
IQWiG found an indication of a considerable added benefit of apixaban for each of two patient groups: Patients who can also be treated with a vitamin K antagonist ...